Literature DB >> 29724922

The reproducibility of COPD blood eosinophil counts.

Thomas Southworth1, Gussie Beech1, Philip Foden2, Umme Kolsum1, Dave Singh1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29724922     DOI： 10.1183/13993003.00427-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  17 in total

1.  Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.

Authors:  Dave Singh; Jadwiga A Wedzicha; Salman Siddiqui; Alberto de la Hoz; Wenqiong Xue; Helgo Magnussen; Marc Miravitlles; James D Chalmers; Peter M A Calverley
Journal:  Respir Res       Date:  2020-09-17

2.  Precision medicine in COPD: review of mepolizumab for eosinophilic COPD.

Authors:  Gabriella Long; Jasmine Wall
Journal:  Breathe (Sheff)       Date:  2018-12

3.  The stability of blood Eosinophils in chronic obstructive pulmonary disease.

Authors:  Gabriella H Long; Thomas Southworth; Umme Kolsum; Gavin C Donaldson; Jadwiga A Wedzicha; Christopher E Brightling; Dave Singh
Journal:  Respir Res       Date:  2020-01-10

4.  The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients.

Authors:  Jung-Ki Yoon; Jung-Kyu Lee; Chang-Hoon Lee; Yong Il Hwang; Hyunkuk Kim; Dongil Park; Ki-Eun Hwang; Sang-Heon Kim; Ki-Suck Jung; Kwang Ha Yoo; Seung Won Ra; Deog Kyeom Kim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-08-31

5.  Triple therapy in chronic obstructive pulmonary disease: consideration under new evidence.

Authors:  Yong-Hua Gao; Rong-Chang Chen
Journal:  Chin Med J (Engl)       Date:  2021-02-15       Impact factor: 2.628

6.  The stability of blood eosinophils in stable chronic obstructive pulmonary disease: a retrospective study in Belgian primary care.

Authors:  Inès Van Rossem; Jan Vandevoorde; Shane Hanon; Sander Deridder; Eef Vanderhelst
Journal:  BMC Pulm Med       Date:  2020-07-22       Impact factor: 3.317

7.  Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality.

Authors:  Ying Zhang; Li-Rong Liang; Shu Zhang; Yong Lu; Yang-Yu Chen; Huan-Zhong Shi; Ying-Xiang Lin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-05-19

8.  Predictive Value of Exhaled Nitric Oxide and Blood Eosinophil Count in the Assessment of Airway Eosinophilia in COPD.

Authors:  Balazs Antus; Csilla Paska; Imre Barta
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-08-25

9.  Exhaled Nitric Oxide in Patients with Stable Chronic Obstructive Pulmonary Disease: Clinical Implications of the Use of Inhaled Corticosteroids.

Authors:  Yong Suk Jo; Junsu Choe; Sun Hye Shin; Hyeon Kyoung Koo; Won Yeon Lee; Yu Il Kim; Seung Won Ra; Kwang Ha Yoo; Ki Suck Jung; Hye Yun Park; Yong Bum Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2020-01

10.  Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study.

Authors:  Jaco Voorham; Simonetta Baldi; Luigi Santoro; Marjan Kerkhof; Marco Contoli; Leonardo M Fabbri; Huib A M Kerstjens; Jose Luis López-Campos; Nicolas Roche; Dave Singh; Claus F Vogelmeier; David B Price
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.